Failure to Complete Required AIMS Assessments for Resident on Psychotropic Medication
Penalty
Summary
A deficiency was identified when the facility failed to ensure that AIMS (Abnormal Involuntary Movement Scale) assessments were completed as required for a resident receiving psychotropic medications. Record review showed that a resident with diagnoses including Alzheimer's disease, anxiety disorder, and major depressive disorder was prescribed Risperidone and other psychotropic medications. The resident's care plans included interventions to monitor for side effects and effectiveness of these medications, as well as to consult with pharmacy and medical staff regarding ongoing need. Despite these interventions, documentation revealed that the last AIMS assessment for this resident was completed in July 2024, with no evidence of subsequent quarterly assessments as required by facility policy. Interviews with staff confirmed that AIMS assessments should be completed on admission and every three months, but the DON was unable to locate any documentation of assessments after July 2024. The facility's policy also recommended quarterly AIMS assessments for residents on psychotropic medications.